News Quantified

Stock Stats

News Stats


All News	{{AllNewsCount}}
News Wires	{{NewsWiresCount}}
Media Monitoring	{{MoreOverCount}}
SEC Edgar Filings	{{SecEdgarFilingsCount}}
Upgrades	{{UpgradesCount}}
Downgrades	{{DowngradesCount}}
Initiated	{{InitiatesCount}}
Reiterated	{{ReiteratesCount}}
Last Earnings	{{LastEarnings}}
Last Earnings EPS	{{LastEps}}
Next Earnings	{{NextEarnings}}

Order Stats

Sub-Penny
{{SubPennyStr}}
Odd Lot
{{OddLotStr}}
Avg. bid-ask spread

{{GetAvgBidAskSpreadForScale}}
Avg. bid / ask size
{{GetAvgBidSizeForScale}} {{GetAvgAskSizeForScale}}

Shares at ask / bid
{{SharesAtAsk_AMP_Str}} {{SharesAtBid_AMP_Str}}
Off exchange
{{OffExchange}}

News

Ocugen CEO to Present at Oppenheimer Movers in Rare Disease Summit [Yahoo! Finance]

Ocugen CEO to Present at Oppenheimer Movers in Rare Disease Summit

How the Narrative Surrounding Ocugen Is Shifting After New Licensing and Analyst Developments [Yahoo! Finance]

Ocugen CEO to Present at NobleCon21—Noble Capital Markets' Twenty-First Annual Emerging Growth Equity Conference [Yahoo! Finance]

Ocugen CEO to Present at NobleCon21—Noble Capital Markets’ Twenty-First Annual Emerging Growth Equity Conference

8/1/2025

08:25 am

ocgn

-4.5%

IN-LINE

5/9/2025

08:01 am

ocgn

-5.6%

BEAT

3/5/2025

07:02 am

ocgn

-4.4%

IN-LINE

3/5/2025

07:02 am

ocgn

-4.4%

IN-LINE

Form 8-K Ocugen, Inc. For: Dec 12

Form SCHEDULE 13G Ocugen, Inc. Filed by: JANUS HENDERSON GROUP PLC

Form 10-Q Ocugen, Inc. For: Sep 30

Form 8-K Ocugen, Inc. For: Nov 05

Form SCHEDULE 13G/A Ocugen, Inc. Filed by: VANGUARD GROUP INC

52 Week High	{{GetCompanyStockInfo.Week52HighValue}} {{GetCompanyStockInfo.Week52HighDate}}
52 Week Low	{{GetCompanyStockInfo.Week52LowValue}} {{GetCompanyStockInfo.Week52LowDate}}

Today’s Volatility	{{VolatilityStr}}
20 Day Volatility	{{Volatility20Str}}

Open	{{GetCompanyStockInfo.Open}}
Prior Close	{{GetCompanyStockInfo.PriorCloseValue}} {{GetCompanyStockInfo.PriorCloseDate}}